Results 31 to 40 of about 405,619 (302)

Fibroblast Growth Factor 23 and the Last Mile [PDF]

open access: yesClinical Journal of the American Society of Nephrology, 2020
Fibroblast growth factor 23 (FGF23) is a bone-derived hormone that regulates phosphorus balance by enhancing urinary phosphorus excretion and inhibiting the synthesis of 1,25-dihydroxyvitamin D [1,25(OH)2D] ([1][1]).
openaire   +2 more sources

A rare cause of atraumatic fractures: case series of four patients with tumor-induced osteomalacia

open access: yesClinical Diabetes and Endocrinology, 2020
Background Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome that presents with hypophosphatemia, bone pain, muscle weakness and fractures.
Debbie W. Chen   +4 more
doaj   +1 more source

Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer

open access: yesFrontiers in Cell and Developmental Biology, 2021
Together with fibroblast growth factors (FGFs) 19 and 21, FGF23 is an endocrine member of the family of FGFs. Mainly secreted by bone cells, FGF23 acts as a hormone on the kidney, stimulating phosphate excretion and suppressing formation of 1,25(OH)2D3 ...
Franz Ewendt   +2 more
doaj   +1 more source

Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis [PDF]

open access: yes, 2019
Background: Etelcalcetide is an intravenous calcimimetic approved for treatment of secondary hyperparathyroidism (sHPT) in patients receiving hemodialysis. Besides lowering parathyroid hormone (PTH), etelcalcetide also significantly reduces fibroblast
Block, Geoffrey A.   +9 more
core   +1 more source

Fibroblast growth factor 23 and bone mineralisation [PDF]

open access: yesInternational Journal of Oral Science, 2015
Fibroblast growth factor 23 (FGF23) is a hormone that is mainly secreted by osteocytes and osteoblasts in bone. The critical role of FGF23 in mineral ion homeostasis was first identified in human genetic and acquired rachitic diseases and has been further characterised in animal models.
Guo, Yu-Chen, Yuan, Quan
openaire   +2 more sources

Fibroblast-growth factor 23 promotes terminal differentiation of ATDC5 cells. [PDF]

open access: yesPLoS ONE, 2017
Fibroblast Growth Factor 23 (FGF23) is well documented as a crucial player in the systemic regulation of phosphate homeostasis. Moreover, loss-of-function experiments have revealed that FGF23 also has a phosphate-independent and local impact on ...
Mathilde Guibert   +3 more
doaj   +1 more source

Serum fibroblast growth factor 23, serum iron and bone mineral density in premenopausal women [PDF]

open access: yes, 2016
Fibroblast growth factor 23 (FGF23) circulates as active protein and inactive fragments. Low iron status increases FGF23 gene expression, and iron deficiency is common. We hypothesized that in healthy premenopausal women, serum iron influences C-terminal
Acton, Anthony   +7 more
core   +1 more source

Phosphorus Restriction Changes the Expression of Fibroblast Growth Factor 23 and Its Receptors in Laying Hens

open access: yesFrontiers in Physiology, 2020
Dietary phosphorus oversupply wastes non-renewable natural resources and raises environmental concerns in animal agriculture. We hypothesized that laying hens do not need large safety margins for dietary phosphorus because of the existence of fibroblast ...
Zhouzheng Ren   +8 more
doaj   +1 more source

Lymphangioleiomyomatosis: circulating levels of FGF23 and pulmonary diffusion [PDF]

open access: yesJornal Brasileiro de Pneumologia, 2023
Objective: Lymphangioleiomyomatosis (LAM) is a rare, destructive disease of the lungs with a limited number of determinants of disease activity, which are a critical need for clinical trials.
Anthony J Esposito   +9 more
doaj   +1 more source

Fibroblast growth factor 23 and cardiovascular disease in patients with chronic kidney disease [PDF]

open access: yes, 2018
Chronic kidney disease (CKD) has been known to be associated with an increased risk of cardiovascular (CV) mortality and morbidity in Japan. Although traditional risk factors contribute to the development of CV disease in CKD patients, they cannot fully ...
NITTA Kosaku
core   +2 more sources

Home - About - Disclaimer - Privacy